CORVUS PHARMACEUTICALS INC's ticker is CRVS and the CUSIP is 221015100. A total of 57 filers reported holding CORVUS PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $12,000 | +9.1% | 1,100 | 0.0% | 0.00% | – |
| Q4 2017 | $11,000 | -35.3% | 1,100 | 0.0% | 0.00% | – |
| Q3 2017 | $17,000 | +30.8% | 1,100 | 0.0% | 0.00% | – |
| Q2 2017 | $13,000 | -40.9% | 1,100 | 0.0% | 0.00% | – |
| Q1 2017 | $22,000 | +46.7% | 1,100 | 0.0% | 0.00% | – |
| Q4 2016 | $15,000 | -16.7% | 1,100 | 0.0% | 0.00% | – |
| Q3 2016 | $18,000 | +20.0% | 1,100 | 0.0% | 0.00% | – |
| Q2 2016 | $15,000 | – | 1,100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 3,749,379 | $18,147,000 | 3.77% |
| VR Adviser, LLC | 3,427,461 | $16,589,000 | 2.13% |
| ADAMS STREET PARTNERS LLC | 3,275,616 | $15,854,000 | 2.04% |
| Telemetry Investments, L.L.C. | 196,168 | $949,000 | 1.28% |
| DC Investments Management, LLC | 50,709 | $245,000 | 0.46% |
| Orbimed Advisors | 6,943,654 | $33,607,000 | 0.37% |
| EcoR1 Capital, LLC | 2,081,077 | $10,072,000 | 0.35% |
| BVF INC/IL | 1,370,947 | $6,635,000 | 0.26% |
| Ikarian Capital, LLC | 757,545 | $3,666,000 | 0.26% |
| CHI Advisors LLC | 165,927 | $803,000 | 0.23% |